New drug trial aims to ease daily life for myasthenia gravis patients
NCT ID NCT06967480
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether the drug ravulizumab can improve daily activities in people with early-stage generalized myasthenia gravis who have a specific antibody (AChR-positive). About 40 participants will receive treatment and be followed for 50 weeks. The main goal is to see if symptoms like muscle weakness get better, helping with tasks like talking, chewing, and breathing.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTI-ACHR ANTIBODY POSITIVE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Clinical Trial Site
RECRUITINGBergamo, Italy
-
Clinical Trial Site
NOT_YET_RECRUITINGBologna, Italy
-
Clinical Trial Site
RECRUITINGBologna, Italy
-
Clinical Trial Site
RECRUITINGBrescia, Italy
-
Clinical Trial Site
RECRUITINGFlorence, Italy
-
Clinical Trial Site
NOT_YET_RECRUITINGImperia, Italy
-
Clinical Trial Site
RECRUITINGLecco, Italy
-
Clinical Trial Site
NOT_YET_RECRUITINGMessina, Italy
-
Clinical Trial Site
RECRUITINGMilan, Italy
-
Clinical Trial Site
NOT_YET_RECRUITINGMilan, Italy
-
Clinical Trial Site
NOT_YET_RECRUITINGNaples, Italy
-
Clinical Trial Site
NOT_YET_RECRUITINGNovara, Italy
-
Clinical Trial Site
NOT_YET_RECRUITINGOrbassano, Italy
-
Clinical Trial Site
NOT_YET_RECRUITINGPadova, Italy
-
Clinical Trial Site
NOT_YET_RECRUITINGPalermo, Italy
-
Clinical Trial Site
RECRUITINGParma, Italy
-
Clinical Trial Site
NOT_YET_RECRUITINGPavia, Italy
-
Clinical Trial Site
NOT_YET_RECRUITINGPisa, Italy
-
Clinical Trial Site
NOT_YET_RECRUITINGRoma, Italy
-
Clinical Trial Site
NOT_YET_RECRUITINGSalerno, Italy
-
Clinical Trial Site
RECRUITINGSan Giovanni Rotondo, 71013, Italy
-
Clinical Trial Site
RECRUITINGSassari, Italy
-
Clinical Trial Site
NOT_YET_RECRUITINGTorino, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Engineered immune cells take aim at debilitating muscle weakness
- New hope for myasthenia gravis: experimental drug CNP-106 enters human trials
- New hope for myasthenia gravis patients: experimental drug enters phase 2 trial
- New drug trial aims to ease muscle weakness in rare disease
- New shot could ease daily struggles for myasthenia gravis patients
- New study lets myasthenia gravis patients rate their own symptoms on a new drug